Perfluorinated carboxylic acids inhibit cyclooxygenase pathway more potently than 12-lipoxygenase pathway in rat platelets

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 83, Issue 4-6, 2010, Pages 225-228

  Sakuma, Satoru ^a   Fujii, Yukari ^a   Abe, Muneyuki ^a   Arakawa, Yukio ^a   Fujimoto, Yohko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

12 lipoxygenase; Cyclooxygenase; Environmental pollutant; Perfluorinated carboxylic acid; Platelet

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; CARBOXYLIC ACID; PERFLUORO COMPOUND; PERFLUORONONANOIC ACID; PERFLUOROOCTANOIC ACID; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME SYNTHESIS; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BLOOD PLATELETS; CACO-2 CELLS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FLUOROCARBONS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; OCTANOIC ACIDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS;

RATTUS;

EID: 78649449379     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.07.003     Document Type: Article

References (35)

1. Henderson W.M., Smith M.A. Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol. Toxicol. Sci. 2007, 95:452-461.
2. Prevedouros K., Cousins I.T., Buck R.C., Koreniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ. Sci. Technol. 2006, 40:32-44.
3. Giesy J.P., Kannan K. Perfluorochemical surfactants in the environment. Environ. Sci. Technol. 2002, 36:146-152.
4. Kudo N., Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 2003, 28:49-57.
5. Ylinen M., Kojo A., Hanhijarvi H., Peura P. Disposition of perfluorooctanoic acid in the rat after single and subchronic administration. Bull. Environ. Contam. Toxicol. 1990, 44:46-53.
6. Vanden Heuvel J.P., Kuslikis B.I., Van Ragelghem M.L., Peterson R.E. Tissue distribution, metabolism and elimination of perfluorooctanoic acid in male and female rats. J. Biochem. Toxicol. 1991, 6:83-92.
7. Kudo N., Suzuki-Nakajima E., Mitsumoto A., Kawashima Y. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice: in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Biol. Pharm. Bull. 2006, 29:1952-1957.
8. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
9. Hamberg M., Samuelsson B. Prostaglandin endoperoxides: novel transformations of arachidonic acid in human platelets. Proc. Natl. Acad. Sci. USA 1974, 71:3400-3404.
10. Dutilh C.E., Haddeman E., Jouvenaz G.H., Ten Hoor F., Nugteren D.H. Study of the two pathways for arachidonate oxygenation in blood platelets. Lipids 1979, 14:241-246.
11. Sekiya F., Takagi J., Usui T., et al. 12S-Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Biochem. Biophys. Res. Commun. 1991, 179:345-351.
12. Fujimoto Y., Ikeda M., Sakuma S. Monochloramine potently inhibits arachidonic acid metabolism in rat platelets. Biochem. Biophys. Res. Commun. 2006, 344:140-145.
13. Fujimoto Y., Nakatani E., Minamino H., Takahashi M., Sakuma S., Fujita T. Effective use of rabbit gastric antral mucosal slices in prostaglandin synthesis and metabolism studies. Biochim. Biophys. Acta 1990, 1044:65-69.
14. Tsunomori M., Fujimoto Y., Muta E., Nishida H., Sakuma S., Fujita T. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. Biochim. Biophys. Acta 1996, 1300:171-176.
15. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 1974, 71:345-349.
16. Hope W.C., Welton A.F., Fiedler-Nagy C., Batula-Bernardo C., Coffey J.W. In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem. Pharmacol. 1983, 32:367-371.
17. Nakadate T., Yamamoto S., Aizu E., Kato R. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn. J. Pharmacol. 1985, 38:161-168.
18. Flower R.J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 1974, 26:33-67.
19. Fujimoto Y., Takai S., Matsuno K., et al. Effect of tert-butyl hydroperoxide on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in rabbit platelets. Prostaglandins Leukot. Essent. Fatty Acids 1992, 47:259-264.
20. Hu W., Jones P.D., DeCoen W., et al. Alterations in cell membrane properties caused by perfluorinated compounds. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 135:77-88.
21. Kay-Mugford P.A., Benn S.J., LaMarre J., Conlon P.D. Cyclooxygenase expression in canine platelets and Madin-Darby canine kidney cells. Am. J. Vet. Res. 2000, 61:1512-1516.
22. Reiter R., Resch U., Sinzinger H. Do human platelets express COX-2?. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:299-305.
23. Meric J.B., Rottey S., Olaussen K., et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit. Rev. Oncol. Hematol. 2006, 59:51-64.
24. Panaretakis T., Shabalina G., Grander D., Shoshan M., DePierre J.W. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Pharmacol. 2001, 173:56-64.
25. Hu X.Z., Hu D.C. Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma HepG2 cells. Arch. Toxicol. 2009, 83:851-861.
26. Shipley J.M., Hurst C.H., Tanaka S.S, et al. trans-Activation of PPARα and induction of PPARα target genes by perfluorooctane-based chemicals. Toxicol. Sci. 2004, 80:151-160.
27. Vanden Heuvel J.P., Thompson J.T., Frame S.R., Gillies P.J. Differential activation of nuclear receptors by perfluorinated fatty acids analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -Β, and -γ, liver X receptor-Β, and retinoid X receptor-α. Toxicol. Sci. 2006, 92:476-489.
28. Guruge K.S., Taniyasu S., Yamashita N., et al. Perfluorinated organic compounds in human blood serum and seminal plasma: a study of urban and rural tea worker populations in Sri Lanka. J. Environ. Monit. 2005, 7:371-377.
29. Keller J.M., Calafat A.M., Kato K., et al. Determination of perfluorinated alkyl acid concentrations in human serum and milk standard reference materials. Anal. Bioanal. Chem. 2010, 397:439-451.
30. Konwick B.J., Tomy G.T., Ismail N., et al. Concentrations and patterns of perfluoroalkyl acids in Georgia, USA surface waters near and distant to a major use source. Environ. Toxicol. Chem. 2008, 27:2011-2018.
31. Stahl T., Heyn J., Thiele H., et al. Carryover of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) from soil to plants. Arch. Environ. Contam. Toxicol. 2009, 57:289-298.
32. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiological investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 1998, 40:614-622.
33. Ehresman D.J., Froehlich J.W., Olsen G.W., Chang S.C., Butenhoff J.L. Comparison of human whole blood, plasma, and serum matrics for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 2007, 103:176-184.
34. Morrison A.R. Biochemistry and pharmacology of renal arachidonic acid metabolism. Am. J. Med. 1986, 80:3-11.
35. Yamamoto S. Molecular mechanism of vascular prostanoid metabolism and circulation control. Nippon Rinsho 1993, 51:1580-1585.